Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries

European Journal of Pharmacology

Volumn 408, Issue 3, 2000, Pages 335-343

  Miller, Mark R ^a   Roseberry, Marc J ^a   Mazzei, Francesca A ^b   Butler, Anthony R ^b   Webb, David J ^a   Megson, Ian L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Blood vessel; Nitric oxide (NO); Organic nitrate; S Nitrosothiol; Tolerance

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; S NITROSOTHIOL; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFICACY; DRUG TOLERANCE; FEMORAL ARTERY; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0034711564     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00777-9     Document Type: Erratum

References (46)

1. Pharmacology of nitroglycerin and long-acting nitrates
2. N(G)-Methyl arginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?
3. Neocuproine, a selective Cu(I) chelator, reversibly inhibits relaxation of rat vascular smooth muscle by S-nitrosothiols
4. Chemical mechanism underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-D,L-penicillamine and S-nitrosoglutathione
5. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover
6. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure
7. Biotransformation of glyceryltrinitrate occurs concurrently with relaxation of rabbit aorta
8. Effect of local intra-arterial N(G)-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal
9. Inhibition and stimulation of nitric oxide synthase in the human forearm arterial bed of patients with insulin-dependent diabetes
10. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs
11. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO)
12. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine
13. Hemoglobin penetration in the wall of the rabbit basilar artery after subarachnoid hemorrhage and intracisternal hemoglobin injection
14. Regional and cardiac haemodynamic effects of N(G)-nitro-L-arginine methyl ester in conscious Long Evans rats
15. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4,]oxodiazolo[4,3a]quinoxalin-1-one
16. Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione
17. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione
18. L-NMMA increases blood pressure in man
19. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates
20. Dissociation of nitrovasodilator relaxation from cyclic GMP levels during in vitro tolerance
21. Tolerance to relaxation in rat aorta: comparison of an S-nitrosothiol with nitroglycerin
22. Selective blockade of endothelium-dependent and glyceryltrinitrate-induced relaxation by hemoglobin, and by methylene blue in the rabbit aorta
23. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross tolerance with nitroglycerin
24. 'Repriming' of vascular smooth muscle photorelaxation is dependent on endothelium-derived nitric oxide
25. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug
26. N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries
27. Development and mechanism of a specific supersensitivity to nitrovasodilators following inhibition of nitric oxide synthase in vivo
28. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo
29. Evidence for enhanced vascular superoxide production in nitrate tolerance
30. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of membrane-bound NADH oxidase
31. Mechanism of tolerance development to organic nitrates
32. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells
33. Nitric oxide release accounts for the biological activity of EDRF
34. Vascular endothelial cells synthesise nitric oxide from L-arginine
35. Transdermal nitroglycerin in angina pectoris
36. Role of endothelium-derived nitric oxide in the regulation of blood pressure
37. Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
38. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits
39. Biotransformation of glyceryltrinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates
40. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin
41. S-Nitrosylation of proteins with nitric oxide: synthesis and characterisation of biologically active compounds
42. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man
43. cGMP synthesis and function
44. Desensitization to nitroglycerin in vascular smooth muscle from rat and human
45. Superoxide and peroxynitrite in atherosclerosis
46. S-nitrosation and the reactions of S-nitroso compounds